Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers

By In The News
June 14, 2021 in The Headlines

Recommended Posts

In The News

Posted June 14, 2021

- Share

Posted June 14, 2021

RALEIGH, N.C., June 14, 2021 /PRNewswire/ -- Inceptor Bio, a Research Triangle Park, North Carolina-based cell and gene therapy biotech, announced today that it is developing multiple next-generation cell and gene therapy platforms to cure difficult-to-treat cancers. Inceptor Bio will...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  221806
2. Jaydee
  17647
3. deicer
  13206
4. Kip Powick
  12292
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.2k
- Total Posts
  
  564.3k

Sign In

Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support